AzTrials
AzTrials

StrokeNCT03208439

Neuromuscular Electrical Stimulation Cycling

A study testing lower-limb cycling system in people with Stroke, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A new electromyography (EMG)-driven neuromuscular electrical stimulation (NMES)-cycling system is introduced to stroke survivors for lower-limb rehabilitation. The system will generate NMES to targeted muscle according to the user's voluntary intention, represented by the EMG signal during cycling. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
lower-limb cycling system
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteHong Kong
Study dates
10 Aug 2017to 1 Jan 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosis of ischemic brain injury or intracerebral hemorrhage shown by magnetic resonance imaging or computed tomography after the onset of stroke;
  • sufficient cognition to follow simple instructions as well as understand the content and purpose of the study;
  • significant gait deficit (Functional Ambulatory Category, FAC, scale <4 [person cannot walk independently]).

Who cannot join

  • any additional medical or psychological condition that would affect their ability to comply with the study protocol, e.g., a significant orthopedic or chronic pain condition, major post-stroke depression;
  • severe hip, knee or ankle contracture that would preclude passive range of motion of the leg;
  • implanted cardiac device (e.g. pacemaker and internal defibrillator).

Trial locations and contacts

1 site in 1 country.

Raymond Kai-yu Tong, PhD contact

+852 3943 8454

kytong@cuhk.edu.hk

Hong Kong1 site, 1 recruiting
  • Department of Biomedical Engineering, The Chinese University of Hong Kong

    Shatin

    Raymond Tong, PhD, +852 3943 8454

    Recruiting

Other trials in Hong Kong

About this study

Official title: Interactive Cycling System Using Electromyography (EMG)-Driven Neuromuscular Electrical Stimulation (NMES) for Rehabilitation

A new electromyography (EMG)-driven neuromuscular electrical stimulation (NMES)-cycling system is introduced to stroke survivors for lower-limb rehabilitation. The system will generate NMES to targeted muscle according to the user's voluntary intention, represented by the EMG signal during cycling.

Conditions
Stroke
Being tested
lower-limb cycling system
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • lower-limb cycling systemDevice

    patients will receive 30-minute cycling exercise

Study groups in NCT03208439
Study groupRoleWhat they receive
EMG-driven NMESExperimentalsubjects will receive EMG-driven NMES cycling exercise.
Receives: Device: lower-limb cycling system
passive pre-programmed NMESPlacebo comparatorsubjects will receive passive pre-programmed NMES during cycling exercise.
Receives: Device: lower-limb cycling system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lower-Extremities Fugl-Meyer Assessment

    Measured: 3-month follow up

Secondary outcomes (5)
  1. Elderly Mobility Scale

    Measured: 3-month follow up

  2. Berg Balance Scale

    Measured: 3-month follow up

  3. 6-Minute Walking Test

    Measured: 3-month follow up

  4. 10-Meter Walk Test

    Measured: 3-month follow up

  5. electroencephalography

    Measured: 3-month follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2017
  2. Study start10 Aug 2017
  3. Primary completion1 Jan 2018 (estimated)
  4. Study completion1 Jan 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03208439
Sponsor's protocol ID
2016.093-T
Status last verified
Sep 2017
First submitted
3 Jul 2017
Last updated
18 Sep 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hu C, Wang T, Leung KWC, Li L, Tong RK. Muscle Electrical Impedance Properties and Activation Alteration After Functional Electrical Stimulation-Assisted Cycling Training for Chronic Stroke Survivors: A Longitudinal Pilot Study. Front Neurol. 2021 Dec 15;12:746263. doi: 10.3389/fneur.2021.746263. eCollection 2021.

    PubMed 34975713

Questions about this trial

What is this clinical trial studying?

A study testing lower-limb cycling system in people with Stroke, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Raymond Kai-yu Tong, PhD (+852 3943 8454, kytong@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lower-Extremities Fugl-Meyer Assessment (time frame: 3-month follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03208439, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in